We are live on ! Find out more
DJYG

David J. Yvars Group Portfolio holdings

AUM $212M
1-Year Est. Return 33.06%
This Fund
S&P 500
This Quarter Est. Return
-5.06%
1 Year Est. Return
+33.06%
3 Year Est. Return
+125.45%
5 Year Est. Return
+204.83%
10 Year Est. Return
AUM
$90M
AUM Growth
+$16.5M
Cap. Flow
+$23.5M
Cap. Flow %
26.07%
Top 10 Hldgs %
61.76%
Holding
67
New
5
Increased
16
Reduced
27
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 17.06%
2 Technology 14.68%
3 Consumer Discretionary 7.81%
4 Financials 4.17%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAI icon
51
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.42B
$244K 0.27%
2,852
-1,805
-39% -$165K
VO icon
52
Vanguard Mid-Cap ETF
VO
$106B
$234K 0.26%
4,972
IWP icon
53
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$228K 0.25%
2,876
T icon
54
AT&T
T
$152B
$221K 0.25%
14,416
+1
+0% +$18
HD icon
55
Home Depot
HD
$338B
$219K 0.24%
793
VGT icon
56
Vanguard Information Technology ETF
VGT
$139B
$208K 0.23%
5,344
NEE icon
57
NextEra Energy
NEE
$185B
$204K 0.23%
2,600
QYLD icon
58
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.08B
$165K 0.18%
10,505
-158
-1% -$2.77K
HYB
59
DELISTED
New America High Income Fund, Inc.
HYB
$139K 0.15%
21,403
+451
+2% +$3.23K
JCE icon
60
Nuveen Core Equity Alpha Fund
JCE
$276M
$133K 0.15%
11,000
PR
61
Permian Resources
PR
$16.9B
$127K 0.14%
18,730
GAB icon
62
Gabelli Equity Trust
GAB
$1.75B
$104K 0.12%
18,935
-3,387
-15% -$20.9K
BTX
63
BlackRock Technology and Private Equity Term Trust
BTX
$935M
$101K 0.11%
+13,892
New +$116K
JPS
64
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$94K 0.1%
14,382
-1,476
-9% -$10.9K
PPT
65
Franklin Premier Income Trust
PPT
$327M
$88K 0.1%
24,499
-1,016
-4% -$3.88K
STIM icon
66
Neuronetics
STIM
$113M
$81K 0.09%
25,620
+10,000
+64% +$36.3K
EVT icon
67
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.02B
-8,660
Closed -$211K

Similar funds

David J. Yvars Group's Q3 2022 Portfolio in Review

As of Q3 2022, David J. Yvars Group held 67 positions worth $90M, up 22% from $73.5M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

David J. Yvars Group deployed $23.5M of net new capital in Q3 2022, opening 5 new positions and adding to 16 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 13,495 shares worth $3.91M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 8.5% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $208K trimmed.

  • David J. Yvars Group's largest Q3 2022 buy was Vertex Pharmaceuticals: 13,495 shares worth $3.91M.
  • David J. Yvars Group added most to State Street Technology Select Sector SPDR ETF in Q3 2022, an estimated $6.06M increase.
  • David J. Yvars Group's biggest Q3 2022 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $208K.
  • David J. Yvars Group fully exited Eaton Vance Tax-Advantaged Dividend Income Fund in Q3 2022, selling an estimated $211K.
  • David J. Yvars Group's ten largest holdings make up 62% of its $90M portfolio in Q3 2022.
  • David J. Yvars Group opened 5 new positions and closed 1 in Q3 2022.
  • David J. Yvars Group's portfolio value rose 22% quarter-over-quarter to $90M.

Based on David J. Yvars Group's 13F filing for Q3 2022, filed 26 Oct 2022.